Peel Hunt Reaffirms Buy Rating for CVS Group (CVSG)

CVS Group (LON:CVSG)‘s stock had its “buy” rating restated by equities research analysts at Peel Hunt in a report issued on Thursday.

CVSG has been the topic of several other reports. Royal Bank of Canada reduced their price objective on CVS Group from GBX 1,190 ($15.55) to GBX 1,180 ($15.42) and set an “outperform” rating on the stock in a research report on Tuesday, October 23rd. Berenberg Bank reduced their price objective on CVS Group from GBX 1,450 ($18.95) to GBX 1,250 ($16.33) and set a “buy” rating on the stock in a research report on Monday, October 1st.

CVSG opened at GBX 839.50 ($10.97) on Thursday. CVS Group has a one year low of GBX 13.22 ($0.17) and a one year high of GBX 1,500 ($19.60).



CVS Group Company Profile

CVS Group plc provides veterinary services in the United Kingdom. The company operates through four segments: Veterinary Practice, Laboratory, Crematoria, and Animed Direct. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste collection services for veterinary practices and directly for pet owners.

Further Reading: Why do company’s buyback their stock?

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply